Email this article 
Present and future of breast cancer anti-Her-2-therapy
- Authors: Letyagin V.P.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: No 2 (2011)
- Pages: 41-44
- Section: MAMMOLOGY. PHARMACOTHERAPY
- Published: 25.05.2011
- URL: https://ojrs.abvpress.ru/ojrs/article/view/160
- DOI: https://doi.org/10.17650/1994-4098-2011-0-2-41-44
- ID: 160
Cite item
Full Text
Abstract
The paper describes a new class of molecular targeted antitumor agents against the molecules involved in carcinogenesis. It considers the basic drugs of this class and their combinations and evaluates the efficiency of their use in therapy for breast cancer.
Keywords
About the authors
V. P. Letyagin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: levipa@mail.ru
Russian Federation
References
Supplementary files
